Education
About Us
Working with TipRanks
Follow Us
Dr. Martens Plc (GB:DOCS)
LSE:DOCS
DOCS Stock Chart & Stats
62.55 p
-1.05 p(-1.49%)
At close: 4:00 PM EST
62.55 p
-1.05 p(-1.49%)
Day’s Range― - ―
52-Week Range43.02 p - 100.87 p
Previous CloseN/A
Volume189.83K
Average Volume (3M)1.82M
Market Cap
£604.61M
Enterprise Value906.00M
Total Cash (Recent Filing)£95.70M
Total Debt (Recent Filing)£397.10M
Price to Earnings (P/E)―
Beta1.67
Next Earnings
May 28, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend Yield3.36%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding967,343,750
10 Day Avg. Volume1,078,739
30 Day Avg. Volume1,820,978
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)1.34
Price to Sales (P/S)0.62
P/FCF Ratio2.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£93.75Price Target Upside49.88% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)0.04
Revenue Forecast (FY)£773.90M
Bulls Say, Bears Say
Bulls Say
Higher‑margin DTC ChannelDr. Martens’ direct‑to‑consumer channel captures higher gross margin and management reports rising full‑price DTC sales. Over the medium term this durable retail capability supports margin sustainability, pricing control, customer data capture, and better unit economics versus wholesale.
Strong Free Cash Flow GenerationThe company converts earnings into cash effectively, showing a meaningful year‑over‑year free cash flow increase and strong operating cash flow to net income conversion. Persistent cash generation underpins reinvestment, working capital flexibility and deleveraging even if earnings remain volatile.
Reduced Net Bank Debt / Manageable LeverageA GBP 33m reduction in net bank debt and reported net debt/EBITDA around 2.1x, alongside a manageable debt/equity profile, materially improves financial flexibility. Lower leverage reduces interest and refinancing risk and creates capacity for strategic investment or shareholder returns.
Bears Say
Declining Revenue TrendSustained top‑line contraction reduces scale advantages, weakens bargaining power with wholesale partners, and places pressure on fixed cost absorption. If revenue decline persists it constrains margin recovery, capex planning and the ability to fund growth initiatives over the medium term.
Severe Drop In Returns And Net MarginROE collapsing alongside a net margin near 0.57% signals a major deterioration in capital efficiency and profitability. Restoring meaningful shareholder returns will require sustained margin expansion or capital restructuring, making recovery a multi‑quarter strategic challenge.
EMEA DTC Weakness And Product/headwind IssuesWeakness in the core EMEA direct channel and noted problems in boots/sandals, plus tariff headwinds, represent structural demand and cost challenges. Persistent regional or category underperformance can impair global growth, inventory turns, and margin consistency over several quarters.
Dr. Martens Plc News
DOCS FAQ
What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest share price was 43.02 p and its highest was 100.87 p in the past 12 months.
What is Dr. Martens Plc’s market cap?
Dr. Martens Plc’s market cap is £604.61M.
When is Dr. Martens Plc’s upcoming earnings report date?
Dr. Martens Plc’s upcoming earnings report date is May 28, 2026 which is in 79 days.
How were Dr. Martens Plc’s earnings last quarter?
Dr. Martens Plc released its earnings results on Nov 20, 2025. The company reported -0.009 p earnings per share for the quarter, the consensus estimate of -0.009 p by 0 p.
Is Dr. Martens Plc overvalued?
According to Wall Street analysts Dr. Martens Plc’s price is currently Undervalued.
Does Dr. Martens Plc pay dividends?
Dr. Martens Plc pays a Semiannually dividend of 0.85 p which represents an annual dividend yield of 3.36%. See more information on Dr. Martens Plc dividends here
What is Dr. Martens Plc’s EPS estimate?
Dr. Martens Plc’s EPS estimate is 0.05.
How many shares outstanding does Dr. Martens Plc have?
Dr. Martens Plc has 967,343,750 shares outstanding.
What happened to Dr. Martens Plc’s price movement after its last earnings report?
Dr. Martens Plc reported an EPS of -0.009 p in its last earnings report, expectations of -0.009 p. Following the earnings report the stock price went down -9.558%.
Which hedge fund is a major shareholder of Dr. Martens Plc?
Currently, no hedge funds are holding shares in GB:DOCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Martens Plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£93.75 (49.88% Upside)
£93.75 (49.88% Upside)
Insider Transactions
Bought Shares
Worth £80.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
69.81%
12-Months-Change
Fundamentals
Return on Equity
4.61%
Trailing 12-Months
Asset Growth
-6.57%
Trailing 12-Months
Company Description
Dr. Martens Plc
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
DOCS Stock 12 Month Forecast
Average Price Target
93.75 p
▲(49.88% Upside)
Technical Analysis
Options Prices
Currently, No data available
---